I 

114TH CONGRESS 

2D SESSION H. R. 5645 

To authorize the Secretary of Health and Human Services to award grants 

for Alzheimer’s disease research. 

IN THE HOUSE OF REPRESENTATIVES 

JULY 6, 2016 

Mr. ISRAEL introduced the following bill; which was referred to the Committee 

on Energy and Commerce 

A BILL 

To authorize the Secretary of Health and Human Services 

to award grants for Alzheimer’s disease research. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘United States-Israel 

5 Alzheimer’s Disease Cooperation Act’’. 

6 SEC. 2. FINDINGS. 

7 The Congress finds the following: 

8 (1) It is in the highest national interests of the 

9 United States to further research into Alzheimer’s 

10 disease. 


SSpencer on DSK4SPTVN1PROD with BILLS
2 

•HR 5645 IH

1 (2) The State of Israel is a steadfast ally of the 

2 United States. 

3 (3) The special relationship between the United 

4 States and Israel is manifested in a variety of coop5 erative scientific research and development pro6 grams, such as— 

7 (A) the United States-Israel Binational 

8 Science Foundation; 

9 (B) the United States-Israel Binational In10 dustrial Research and Development Founda11 tion; and 

12 (C) the United States-Israel Energy Co13 operation Act. 

14 (4) Those programs have made possible many 

15 scientific, technological, and commercial break16 throughs in fields including the life sciences, medi17 cine, bioengineering, agriculture, biotechnology, com18 munications, and energy development. 

19 (5) Israeli scientists are at the forefront of re20 search and development in the field of Alzheimer’s 

21 disease. 

22 (6) Enhanced cooperation between the United 

23 States and Israel for the purpose of research in Alz24 heimer’s disease would be in the national interests of 

25 both countries. 


SSpencer on DSK4SPTVN1PROD with BILLS
3 

•HR 5645 IH

1 SEC. 3. GRANTS FOR ALZHEIMER’S DISEASE RESEARCH. 

2 (a) GRANT PROGRAM.— 

3 (1) ESTABLISHMENT.—The Secretary of Health 

4 and Human Services (in this section referred to as 

5 the ‘‘Secretary’’) shall establish a program of award6 ing grants to support research on the development 

7 and commercialization of applicable tools, treat8 ments, and cures for Alzheimer’s disease and other 

9 dementias. 

10 (2) ELIGIBLE PROJECTS.—To be eligible for 

11 funding under this section, a project shall— 

12 (A) be designed to further research de13 scribed in paragraph (1); and 

14 (B) be a joint venture between— 

15 (i)(I) a for-profit business entity, aca16 demic institution, National Laboratory (as 

17 defined in section 2 of the Energy Policy 

18 Act of 2005 (42 U.S.C. 15801)), or non19 profit entity in the United States; and 

20 (II) a for-profit business entity, aca21 demic institution, or nonprofit entity in 

22 Israel; or 

23 (ii)(I) the Federal Government; and 

24 (II) the Government of Israel. 

25 (3) APPLICATIONS.—To seek a grant under this 

26 section, an applicant shall submit to the Secretary 


SSpencer on DSK4SPTVN1PROD with BILLS
4 

•HR 5645 IH

1 an application in accordance with procedures estab2 lished by the Secretary, in consultation with the ad3 visory board established under paragraph (4). 

4 (4) ADVISORY BOARD.— 

5 (A) ESTABLISHMENT.—The Secretary 

6 shall establish an advisory board— 

7 (i) to monitor the method by which 

8 grants are awarded under this section; and 

9 (ii) to provide to the Secretary peri10 odic performance reviews of actions taken 

11 to carry out this section. 

12 (B) COMPOSITION.—The advisory board 

13 established under subparagraph (A) shall be 

14 composed of 3 members, to be appointed by the 

15 Secretary, of whom— 

16 (i) 1 shall be a representative of the 

17 Federal Government; 

18 (ii) 1 shall be selected from a list of 

19 nominees provided by the United States20 Israel Binational Science Foundation; and 

21 (iii) 1 shall be selected from a list of 

22 nominees provided by the United States23 Israel Binational Industrial Research and 

24 Development Foundation. 


SSpencer on DSK4SPTVN1PROD with BILLS
5 

•HR 5645 IH

1 (5) CONTRIBUTED FUNDS.—Notwithstanding 

2 section 3302 of title 31, United States Code, the 

3 Secretary may accept, retain, and use funds contrib4 uted by any person, government entity, or organiza5 tion for purposes of carrying out this section— 

6 (A) without further appropriation; and 

7 (B) without fiscal year limitation. 

8 (6) REPORT.—Not later than 180 days after 

9 the date of completion of a project for which a grant 

10 is provided under this section, the grant recipient 

11 shall submit to the Secretary a report that con12 tains— 

13 (A) a description of the method by which 

14 the recipient used the grant funds; and 

15 (B) an evaluation of the level of success of 

16 each project funded by the grant. 

17 (7) CLASSIFICATION.—Grants shall be awarded 

18 under this section only for projects that are consid19 ered to be unclassified by both the United States 

20 and Israel. 

21 (b) TERMINATION.—The grant program and the ad22 visory committee established under this section terminate 

23 on the date that is 7 years after the date of enactment 

24 of this Act. 


SSpencer on DSK4SPTVN1PROD with BILLS
6 

•HR 5645 IH

1 (c) AUTHORIZATION OF APPROPRIATIONS.—There is 

2 authorized to be appropriated to carry out this section 

3 $3,000,000 for the period of fiscal years 2017 through 

4 2023. Any amounts appropriated pursuant to this sub5 section shall be in addition to amounts accepted, retained, 

6 and used pursuant to subsection (a)(5). 

Æ 


SSpencer on DSK4SPTVN1PROD with BILLS